EN_01523751_0017
  • 12,00 EUR

    Making print for private purpose, storage in computer memory, no distribution rights.

  • 20,00 EUR

    Strictly for editorial, single use on a web site, Internet portal, social media (Facebook, Instagram etc.), blog or for personal use for 1 year. Not for resale.

  • 50,00 EUR

    Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices
Contact us to calculate price for another use. Prices only for online sales.
Eden on a day out. HOLMFIRTH, UK: THIS FAMILY has shared how they have raised more than L400k for the treatment of their seven-year-old's rare cancer. Eden Smith (7) from Holmfirth, UK, was diagnosed with neuroblastoma in April 2021 after some seemingly innocuous pains in her legs. Neuroblastoma is a rare form of childhood cancer which affects fewer than 100 children in the UK each year and has a 40-50% long-term survival rate. Determined to help their daughter in any way they could, dad Lee (47) and mum Jen (47) started raising money for cancer charities, and after reading about a trial vaccine that could improve Eden's chances, threw themselves into building a fund for her. mediadrumimages/Lee Smith
Rodzina zebrała 400 tys. funtów na leczenie syna
2022-05-11
mediadrumimages/Lee Smith/Media Drum/East News
Media Drum
mediadrumimages/Lee Smith
h_MDRUM_400k_Neuroblastoma_Treatment-11
0,17MB
7cm x 9cm by 300dpi
100, 2021, 40-50, 47, 7, A, ABOUT, AFFECTS, AFTER, AND, ANY, APRIL, BUILDING, CANCER, CHANCES, CHARITIES, CHILDHOOD, CHILDREN, COULD, DAD, DAUGHTER, DAY, DETERMINED, DIAGNOSED, EACH, EDEN, FAMILY, FEWER, FOR, FORM, FROM, FUND, HAS, HAVE, HELP, HER, HOLMFIRTH, HOW, IMPROVE, IN, INNOCUOUS, INTO, IS, JEN, L400K, LEE, LEGS, LONG-TERM, MEDIADRUMIMAGES, MONEY, MORE, MUM, NEUROBLASTOMA, OF, ON, OUT, PAINS, RAISED, RAISING, RARE, RATE, READING, SEEMINGLY, SEVEN-YEAR-OLD, SHARED, SMITH, SOME, STARTED, SURVIVAL, THAN, THAT, THE, THEIR, THEMSELVES, THEY, THIS, THREW, TO, TREATMENT, TRIAL, UK, VACCINE, WAS, WAY, WHICH, WITH, YEAR,